Flavonoid Nanocarriers Improve Preclinical Drug Delivery but Face Major Clinical Translation Hurdles
A systematic review reveals that while nanocarriers overcome flavonoid bioavailability barriers in preclinical inflammatory models, clinical evidence remains restricted to ...




